Kourtney Kardashian’s new Lemme supplement lives up to the Ozempic hype

Kourtney Kardashian’s wellness brand Lemme launched a new weight loss supplement today, saying in a press release that it provides “significant weight management benefits.” Because the product is a supplement, Lemme’s claims have not been evaluated or approved by the Food and Drug Administration.

The supplement, called GLP-1 Daily, is made from ingredients such as lemon fruit extract, saffron extract, and orange extract. It is priced at $72 per month.

Although the supplement is not a GLP-1 receptor agonist like Ozempic or other trendy weight loss drugs, Lemme says it helps increase GLP-1 levels naturally. This gut hormone plays a crucial role in regulating blood sugar levels and suppressing appetite.

Kourtney Kardashian Barker founded Lemme in 2022 and launch with a line of vitamins and supplements.

Lemme isn’t the only health and wellness company jumping on the diet drug bandwagon. Growing sales of prescription weight-loss drugs transformed Novo Nordisk (NGOs) and Eli Lilly (LLY) in to the most valuable pharmaceutical companies in the world. The incessant demand for these treatments has also led to continuous shortages and even boosted Denmark’s GDP last year.

Morgan Stanley analysts estimate that the global market for GLP-1 prescription drugs could reach $105 billion by 2030. With so much money at stake, a number of companies, from Costco (COST) to LifeTime Fitness—started selling these drugs. Additionally, millennial-focused telehealth companies Hims & Hers (HE) and Ro now offer cheaper, off-brand alternatives.

Read more